MedTrace Logo

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

NCT02395003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-02-26

No results posted yet for this study

Summary

Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adolescents.

Conditions

  • Pediatric Obesity

Interventions

OTHER

Palmitate Diet

Subject with high VAT/SAT ratio will be randomized to a high or low palmitate oil diet.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Sonia Caprio, MD · Yale University

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2023-03-07
Completion
2023-03-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02395003 on ClinicalTrials.gov